Temat: "Immunoglobulin Idiotypes" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Immune modulation and possible pathological implications mediated by naturally produced immunoglobulin G idiotypes: from historical to recent experimental and clinical studies focused on atopic dermatitis.
Autorzy:: Santander, Lucas
Rakanidis Machado, Nicolle
Oliveira Fagundes, Beatriz
Victor, Jefferson Russo; Pokaż więcej
Źródło:: Clinical & Experimental Vaccine Research. Jan2024, Vol. 13 Issue 1, p1-9. 9p.

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Idiotopes of antibodies against HIV‐1 CD4‐induced epitope shared with those against microorganisms.
Autorzy:: Biswas, Shashwata (AUTHOR)
Kuwata, Takeo (AUTHOR)
Yamauchi, Soichiro (AUTHOR)
Okazaki, Kyo (AUTHOR)
Kaku, Yu (AUTHOR)
Hasan, Md Zahid (AUTHOR)
Morioka, Hiroshi (AUTHOR)
Matsushita, Shuzo (AUTHOR); Pokaż więcej
Źródło:: Immunology. Apr2024, Vol. 171 Issue 4, p534-548. 15p.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma.
Autorzy:: Casales E; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.
Martisova E; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.
Villanueva H; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Aptamer Platform, Molecular Therapeutics Program, Cima Universidad de Navarra, Pamplona, Spain.
de Cerio ALD; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Department of Hematology and Cell Therapy Area, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain.
Inoges S; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Department of Hematology and Cell Therapy Area, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain.
Silva-Pilipich N; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.
Ballesteros-Briones MC; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.
Aranda A; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.
Bezunartea J; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.
Bendandi M; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Department of Hematology and Cell Therapy Area, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain.; Section On Hematology/Oncology, Wake Forest University Comprehensive Cancer Center, Winston-Salem, NC, USA.; Section of Hematology/Oncology, VA Medical Center, Salisbury, NC, USA.
Pastor F; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Aptamer Platform, Molecular Therapeutics Program, Cima Universidad de Navarra, Pamplona, Spain.
Smerdou C; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain. .; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Nov 02; Vol. 11 (1), pp. 21427. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Alphavirus/*genetics
Antibodies, Monoclonal/*administration & dosage
Cancer Vaccines/*administration & dosage
Genetic Vectors/*administration & dosage
Immunoglobulin Idiotypes/*immunology
Lymphoma, B-Cell/*therapy
Vaccination/*methods
Animals ; Antibodies, Monoclonal/immunology ; Apoptosis ; Cancer Vaccines/genetics ; Cancer Vaccines/immunology ; Cell Proliferation ; Female ; Genetic Vectors/genetics ; Humans ; Lymphoma, B-Cell/immunology ; Lymphoma, B-Cell/pathology ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Jerne's "immune network theory", of interacting anti‐idiotypic antibodies applied to immune responses during COVID‐19 infection and after COVID‐19 vaccination.
Autorzy:: Kurbel, Sven; Pokaż więcej
Temat:: COVID-19
COVID-19 pandemic
COVID-19 vaccines
IMMUNE response
IMMUNOGLOBULIN idiotypes
IMMUNOGLOBULINS
Źródło:: BioEssays; Sep2023, Vol. 45 Issue 9, p1-9, 9p
Przedsiębiorstwo/ jednostka:: EUROPEAN Medicines Agency

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: Expression of the inherently autoreactive idiotope 9G4 on autoantibodies to citrullinated peptides and on rheumatoid factors in patients with early and established rheumatoid arthritis.
Autorzy:: Cambridge G; Centre for Rheumatology, University College London, London, United Kingdom.
Moura RA; Centre for Rheumatology, University College London, London, United Kingdom; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Santos T; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Khawaja AA; Centre for Rheumatology, University College London, London, United Kingdom; Centre for Inflammation and Tissue Repair, University College London, London, United Kingdom.
Polido-Pereira J; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal; Rheumatology Department, Centro Hospitalar de Lisboa Norte, EPE, Hospital de Santa Maria, Lisbon, Portugal.
Canhão H; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal; Rheumatology Department, Centro Hospitalar de Lisboa Norte, EPE, Hospital de Santa Maria, Lisbon, Portugal.
Leandro MJ; Centre for Rheumatology, University College London, London, United Kingdom.
Fonseca JE; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal; Rheumatology Department, Centro Hospitalar de Lisboa Norte, EPE, Hospital de Santa Maria, Lisbon, Portugal.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Sep 15; Vol. 9 (9), pp. e107513. Date of Electronic Publication: 2014 Sep 15 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibodies, Monoclonal/*biosynthesis
Arthritis, Rheumatoid/*immunology
Immunoglobulin Idiotypes/*immunology
Peptides, Cyclic/*immunology
Rheumatoid Factor/*immunology
Adult ; Aged ; Animals ; Antibodies, Monoclonal/blood ; Antibodies, Monoclonal/immunology ; Arthritis, Rheumatoid/blood ; Arthritis, Rheumatoid/pathology ; B-Lymphocytes/immunology ; Epitopes/immunology ; Female ; Humans ; Immunoglobulin Idiotypes/blood ; Male ; Middle Aged ; Peptides, Cyclic/biosynthesis ; Peptides, Cyclic/blood ; Rats ; Rheumatoid Factor/blood

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Affinity-matured variants derived from nimotuzumab keep the original fine specificity and exhibit superior biological activity.
Autorzy:: Tundidor Y; Center of Molecular Immunology, calle 216 esq 15, PO Box 16040, Atabey, Playa, CP, 11300, La Habana, Cuba.
Ponce LF; Center of Molecular Immunology, calle 216 esq 15, PO Box 16040, Atabey, Playa, CP, 11300, La Habana, Cuba.
Chao L; Center of Molecular Immunology, calle 216 esq 15, PO Box 16040, Atabey, Playa, CP, 11300, La Habana, Cuba.
Solozábal J; Center of Molecular Immunology, calle 216 esq 15, PO Box 16040, Atabey, Playa, CP, 11300, La Habana, Cuba.
Hust M; Technische Universität Braunschweig, Institute of Biochemistry, Biotechnology and Bioinformatics, Department of Biotechnology, Spielmannstraße 7, 38106, Braunschweig, Germany.
Dübel S; Technische Universität Braunschweig, Institute of Biochemistry, Biotechnology and Bioinformatics, Department of Biotechnology, Spielmannstraße 7, 38106, Braunschweig, Germany.
Rojas G; Center of Molecular Immunology, calle 216 esq 15, PO Box 16040, Atabey, Playa, CP, 11300, La Habana, Cuba. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Jan 27; Vol. 10 (1), pp. 1194. Date of Electronic Publication: 2020 Jan 27.
Typ publikacji:: Journal Article
MeSH Terms:: Antibodies, Monoclonal, Humanized/*immunology
Antibodies, Monoclonal, Humanized/*pharmacology
Antibody Affinity/*immunology
Neoplasms/*immunology
Antibodies, Monoclonal, Humanized/metabolism ; Bacteriophages/genetics ; Bacteriophages/immunology ; Cell Line, Tumor ; Computer Simulation ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Genetic Vectors/genetics ; Humans ; Immunoglobulin Idiotypes/immunology ; Immunoglobulin Variable Region/genetics ; Neoplasms/pathology ; Recombinant Proteins/immunology ; Transfection

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Immunoglobulin G amplifies the production of regulatory rheumatoid factor in vitro through idiotype-anti-idiotype interactions.
Autorzy:: Beduleva L; Laboratory of Biocompatible Materials, Udmurt Federal Research Center UB RAS, Izhevsk, Russian Federation.
Stolyarova E; Laboratory of Biocompatible Materials, Udmurt Federal Research Center UB RAS, Izhevsk, Russian Federation.
Sidorov A; Laboratory of Biocompatible Materials, Udmurt Federal Research Center UB RAS, Izhevsk, Russian Federation.
Khramova T; Laboratory of Biocompatible Materials, Udmurt Federal Research Center UB RAS, Izhevsk, Russian Federation.
Terentiev A; Laboratory of Biocompatible Materials, Udmurt Federal Research Center UB RAS, Izhevsk, Russian Federation.
Menshikov I; Laboratory of Biocompatible Materials, Udmurt Federal Research Center UB RAS, Izhevsk, Russian Federation.
Abisheva N; Laboratory of Biocompatible Materials, Udmurt Federal Research Center UB RAS, Izhevsk, Russian Federation.
Snigiryev A; Laboratory of Biocompatible Materials, Udmurt Federal Research Center UB RAS, Izhevsk, Russian Federation.
Fomina K; Laboratory of Biocompatible Materials, Udmurt Federal Research Center UB RAS, Izhevsk, Russian Federation.; Pokaż więcej
Źródło:: Journal of immunoassay & immunochemistry [J Immunoassay Immunochem] 2020; Vol. 41 (2), pp. 219-230. Date of Electronic Publication: 2020 Jan 12.
Typ publikacji:: Journal Article
MeSH Terms:: Immunoglobulin G/*immunology
Immunoglobulin Idiotypes/*immunology
Rheumatoid Factor/*biosynthesis
Animals ; Cells, Cultured ; Lymphocytes/immunology ; Rats ; Rats, Wistar ; Rheumatoid Factor/blood ; Rheumatoid Factor/immunology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates.
Autorzy:: Rawi R; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
Mall R; Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, 34110, Qatar.
Shen CH; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
Farney SK; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
Shiakolas A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
Zhou J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
Bensmail H; Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, 34110, Qatar.
Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
Doria-Rose NA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
Lynch RM; Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA.
Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
Chuang GY; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2019 Oct 11; Vol. 9 (1), pp. 14696. Date of Electronic Publication: 2019 Oct 11.
Typ publikacji:: Clinical Trial; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Data Accuracy*
Deep Learning*
Broadly Neutralizing Antibodies/*immunology
Drug Resistance, Viral/*immunology
HIV Antibodies/*immunology
HIV Infections/*immunology
HIV-1/*immunology
Binding Sites, Antibody ; Computer Simulation ; Epitope Mapping/methods ; HIV Infections/virology ; HIV-1/classification ; Humans ; Immunoglobulin Idiotypes/immunology ; Neutralization Tests ; Prognosis ; env Gene Products, Human Immunodeficiency Virus/immunology